当前位置:首页 / 亮丙瑞林联合腹腔镜子宫肌瘤剔除术对子宫肌瘤患者激素水平的影响
临床研究 | 更新时间:2018-11-02
|
亮丙瑞林联合腹腔镜子宫肌瘤剔除术对子宫肌瘤患者激素水平的影响
Effect of leuprolide combined with laparoscopic myomectomy on hormone levels in patients with hysteromyoma

微创医学 201813卷05期 页码:633-635+644

作者机构:天津市咸水沽医院妇产科,天津市300350

基金信息:

DOI:DOI:10.11864/j.issn.1673.2018.05.20

  • 中文简介
  • 英文简介
  • 参考文献
目的研究亮丙瑞林联合腹腔镜子宫肌瘤剔除术对子宫肌瘤患者激素水平、月经及子宫肌瘤复发率的影响。方法选取子宫肌瘤患者80例作为研究对象,按照随机数字表法分为研究组和对照组各40例。对照组行腹腔镜下子宫肌瘤剔除术;研究组术前给予亮丙瑞林治疗3个月,再行腹腔镜下子宫肌瘤剔除术。比较两组血清激素水平、月经情况、肌瘤体积及子宫肌瘤复发率等情况。结果治疗后,研究组黄体生成素、血清雌二醇、卵泡刺激素水平均显著低于对照组(P<0.05)。研究组给予亮丙瑞林治疗后,月经期、月经周期与给药前相比无明显变化(P>0.05);但月经量明显少于给药前,子宫体积、肌瘤体积明显小于给药前(P<0.05)。两组手术时间比较,差异无统计学意义(P>0.05)。研究组术中出血量、盆腔引流量明显少于对照组,下床活动时间、住院时间显著短于对照组,差异均有统计学意义(P<0.01)。对患者进行为期半年的随访,所有患者子宫均恢复至正常状态,月经量恢复正常,贫血症状有所缓解或消失,未见复发。结论腹腔镜下子宫肌瘤剔除术前应用亮丙瑞林治疗的临床疗效和安全性均较好,可显著降低患者的血清激素水平,改善月经量,值得应用推广。
ObjectiveTo study the effect of leuprolide combined with laparoscopic myomectomy on hormone levels,menstruation and the recurrence rate of hysteromyoma in the patients with hysteromyoma. MethodsEighty patients with hysteromyoma were enrolled and were divided into study group (n=40) and control group (n=40) according to random table method. The control group underwent laparoscopic myomectomy. The study group was administered leuprorelin for 3 months before operation then underwent laparoscopic myomectom.The levels of serum hormones,menstruation, hysteromyoma volume and recurrence rate of hysteromyoma were compared between the two groups. ResultsAfter treatment, the levels of luteinizing hormone, serum estradiol and follicular stimulating hormone in the study group were significantly lower than those in the control group (P<0.05). After administration of leuprolide in the study group, no obvious changes in the menstrual duration and menstrual cycle were found compared to the levels before administration(P>0.05), but the menstrual volume, uterine volume and tumor volume was significantly less or smaller than those before treatment (P<0.05). There was no significant difference in the operative duration between the two groups (P>0.05). The intraoperative blood loss and pelvic drainage volume were significantly less, and the duration for ambulation and hospital stay were significantly shorter in the study group compared to the control group (P<0.01). Half-year follow-up was conducted in all patients. In all cases, the uteruses recovered to the normal condition, the menstrual volume was normalized, anemia was relieved or disappeared, and no recrudesce occurred. ConclusionBefore laparoscopic myomectomy, application of leuprolide can obtain good clinical efficacy and safety, significantly reduce the serum hormone level of the patients, improve menstrual volume, and is worthy of application and promotion.

2293

浏览量

914

下载量

0

CSCD

工具集